Titre:
  • Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.
Auteur:Paridaens, R.; Dirix, Luc Y; Lohrisch, C; Beex, Louk; Nooij, Marianne; Cameron, David A; Biganzoli, Laura; Cufer, T; Duchateau, L; Hamilton, Andrew; Lobelle, Jean Pierre; Piccart-Gebhart, Martine; European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBBC),
Informations sur la publication:Annals of oncology, 14, 9, page (1391-1398)
Statut de publication:Publié, 2003-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Aged, 80 and over
Androstadienes -- adverse effects
Androstadienes -- therapeutic use
Antineoplastic Agents, Hormonal -- adverse effects
Antineoplastic Agents, Hormonal -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- secondary
Female
Humans
Middle Aged
Postmenopause
Tamoxifen -- adverse effects
Tamoxifen -- therapeutic use
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase II
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:pmid/12954578